Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Kesimpta Pregnancy and Infant Safety Study Using Real World Data
- Status
- RECRUITING
- Phase
- N/A
Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
- Status
- RECRUITING
- Phase
- N/A
A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Real-World Usage of Asciminib Among Patients With Chronic Myeloid Leukemia in Chronic Phase in the United States Using a Large Claims Database
- Status
- COMPLETED
- Phase
- N/A
A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure
- Status
- TERMINATED
- Phase
- PHASE2
Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Status
- RECRUITING
- Phase
- PHASE3
Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR
- Status
- COMPLETED
- Phase
- PHASE1
WOE of Anti-CD20 Therapies
- Status
- COMPLETED
- Phase
- N/A
A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)
- Status
- COMPLETED
- Phase
- PHASE2
Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China
- Status
- COMPLETED
- Phase
- N/A
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP
- Status
- COMPLETED
- Phase
- PHASE2
Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate
- Status
- COMPLETED
- Phase
- NA
Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE Study
- Status
- COMPLETED
- Phase
- N/A